Disclosure of Phase III Clinical Results of Hausen's Class 1 New Drug "Imitenofovir"
The market demand cannot hold up to 84 PD-1/L1 products, what will the latecomers survive?
FDA approves the first non-stimulant ADHD therapy in ten years, which is expected to benefit nearly 1 in 10 children
The first phase III study of Bristol-Myers Squibb PD-1+LAG-3 combination therapy is successful
The BD strategy behind the PD-1 business war
Dongyang Pharmaceutical Group 1 new drugs are coming, 8 innovative drugs hit hard
Anhui No. 1 Middle School hangs up a sign to celebrate the son-in-law of the school won the Nobel Prize (photo)
Tianjing Bio and ABL Bio announced the completion of TJ-L14B Phase 1 clinical trial in the United States...
The Ministry of Finance implements the preferred stock policy: the transferor’s transaction stamp tax rate is 1‰
National Class 1
Talking about: Application of QbD in Drug Development (Part 1)
PD-1 immunotherapy drug Tuoyi® urothelial cancer indication approved in China
Type 1 diabetes research drug TTP399 was awarded the title of breakthrough therapy by FDA
The central bank cuts the RRR, whether the demand for construction emulsion can usher in a recovery
The smell of paint wafts from the underground garage of Shanghai No. 1 Residential Quarter: Hazardous substances exceed the standard by 20 times
Industry | Xiangyang chemical companies cleared within 1 km along the Han River
An explosion in a chemical plant in Huixian County, Henan Province killed 1 person
Industry | Industrial production accelerates "recovery"
Industry | Only 1/3 achieve double profit!
The steady development of the industrial economy and the recovery of key industries with high quality